Evidence map›Paper›PMID 42312075›Full record

ArticleClinical immunology communications2026

Discordant Outcomes of SARS-CoV-2 Exposure in Household Contacts.

Yeji Lee, Alison Tarke, Tertuliano Alves Pereira Neto, Emil Johansson, Benjamin Goodwin, Adam Abawi, April Frazier, Jennifer M Dan, Shane Crotty, Alba Grifoni and 2 more

Abstract read
In one paragraph

Article in Clinical immunology communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yeji LeeCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Alison TarkeCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Tertuliano Alves Pereira NetoCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Emil JohanssonCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Benjamin GoodwinCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Adam AbawiCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
April FrazierCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Jennifer M DanCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Shane CrottyCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Alba GrifoniCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Alessandro SetteCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Ricardo da Silva AntunesCenter for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.

Funding

Single-cell atlas of lung tissue-resident memory T cells reactive to upper and lower respiratory tract pathogensU19AI118626 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Gregory Seumois · 2015 to 2026
$36.7M
T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitisU19AI142742 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Shane P Crotty · 2019 to 2026
$32.8M
Large Scale T Cell Epitope Discovery:Global identification of epitopes derived from Zika (ZIKV), Chikungunya (CHIKV) viruses following natural infection and vaccination75N93019C00065 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI MITCHELL, MAYA · 2019 to 2023
$7.3M
NIAID NIH HHS 75N93019C00065NIAID NIH HHS U19 AI118626NIAID NIH HHS U19 AI142742
6 · The paper itself

Abstract

Background: We investigated discordant SARS-CoV-2 infection outcomes among household contacts. Methods: 95 recently-exposed household contacts were recruited from June 2020 to February 2023 in a prospective study of "discordant pairs", where one individual experienced documented SARS-CoV-2 infection while another close contact consistently tested negative despite shared living arrangements. We collected pre- and post-infection samples and analyzed both SARS-CoV-2 and common cold coronavirus (CCC)-specific T cell responses, as well as spike RBD neutralizing and nucleocapsid-binding antibody titers. Results: Antibody and cellular immune responses did not identify a single predominant mechanism explaining discordant outcomes. Instead, we observed distinct immunological patterns that could be associated with protection from infection across different household contacts. In ~40% of cases, uninfected individuals showed pre-existing immunity to non-spike antigens and CCC sequences. Moreover, 30% of uninfected individuals displayed evidence suggestive of abortive infections, characterized by increased T responses without detectable changes in antibody levels. The remaining cases showed no clear changes in immunological patterns. Conclusions: Multiple immunity-associated factors operate in household settings for SARS-CoV-2-exposed individuals who do not develop overt infection, including both pre-existing immunity and abortive or transient infections. Although causality cannot be established without additional functional assays, this diversity of protective immune responses might help explain why some individuals remain uninfected despite close contact with SARS-CoV-2-positive household members.

Indexed as

Breakthrough infectionHousehold contactspre-existing immunitySARS-CoV-2T cells

Identifiers

PMID42312075
PMCPMC13271679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.